Open access · CC-BY
via OpenAlex
Intravenously Administered, Retinoid Activating Nanoparticles Increase Lifespan and Reduce Neurodegeneration in the SOD1G93A Mouse Model of ALS
David X. Medina, Eugene P. Chung, Collin D. Teague, Robert P. Bowser, Rachael W. Sirianni
Frontiers in Bioengineering and Biotechnology · 2020 · ▲ 47 citations
Abstract
Dysregulation of the retinoic acid (RA) signaling pathway is observed in amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders. Here, we investigated the therapeutic potential of retinoid activation via the RA receptor β (RARβ) in the SOD1G93A mouse model of ALS. Our approach utilized the RARβ agonist adapalene, which we previously found to be neuroprotective in vitro. Adapalene, like most retinoids, is poorly water soluble, which has thus far prevented effective drug delivery in vivo. To address this challenge, we encapsulated adapalene within nanoparticles (Adap-NPs) composed of poly(lactic acid)-poly(ethylene glycol) (PLA-PEG). Our data demonstrate that intravenous administration of Adap-NPs robustly activates retinoid signaling in the CNS. Chronic administration of Adap-NPs resulted in improved motor performance, prolonged lifespan, and neuroprotection in SOD1G93A mice. This study highlights retinoid signaling as a valuable therapeutic approach and presents a novel nanoparticle platform for the treatment of ALS.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fbioe.2020.00224
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Medina, D.X., Chung, E.P., Teague, C.D., Bowser, R.P., & Sirianni, R.W. (2020). Intravenously Administered, Retinoid Activating Nanoparticles Increase Lifespan and Reduce Neurodegeneration in the SOD1G93A Mouse Model of ALS. <em>Frontiers in Bioengineering and Biotechnology</em>. https://doi.org/10.3389/fbioe.2020.00224
Vancouver
Medina DX, Chung EP, Teague CD, Bowser RP, Sirianni RW. Intravenously Administered, Retinoid Activating Nanoparticles Increase Lifespan and Reduce Neurodegeneration in the SOD1G93A Mouse Model of ALS. Frontiers in Bioengineering and Biotechnology. 2020. doi:10.3389/fbioe.2020.00224.
BibTeX
@article{david2020Intrav,
title = {Intravenously Administered, Retinoid Activating Nanoparticles Increase Lifespan and Reduce Neurodegeneration in the SOD1G93A Mouse Model of ALS},
author = {David X. Medina and Eugene P. Chung and Collin D. Teague and Robert P. Bowser and Rachael W. Sirianni},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2020},
doi = {10.3389/fbioe.2020.00224},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Clinical Investigation 2026
Open access · CC-BY
UA-30 ameliorates motor deficits through RalA-mediated mitophagy in ALS mice
Molecules 2022
Open access · CC-BY
Ellagic Acid Increases Stress Resistance via Insulin/IGF-1 Signaling Pathway in Caenorhabditis elegans
Nutrients 2025
Open access · CC-BY
Urolithin A Exhibits Antidepressant-like Effects by Modulating the AMPK/CREB/BDNF Pathway
Drug Development Research 2024
Open access · OA
Xanthones with multiple roles against diabetes: their synthesis, structure‐activity relationship, and mechanism studies
Aging and Disease 2025
Open access · CC-BY
Pharmacological Activation of Mitophagy Confers Neuroprotective Benefits for Amyotrophic Lateral Sclerosis
Scholarly Commons (University of Pennsylvania) 2012
Preprint · OA